Reviva Pharmaceuticals Holdings, Inc.RVPHNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank90
3Y CAGR+13.5%
5Y CAGR+19.1%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
+13.5%/yr
vs -44.5%/yr prior
5Y CAGR
+19.1%/yr
Recent deceleration
Acceleration
+58.0pp
Accelerating
Percentile
P90
Near historical high
vs 5Y Ago
2.4x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 54.00% |
| Q2 2025 | 7.69% |
| Q1 2025 | 18.75% |
| Q4 2024 | 36.00% |
| Q3 2024 | 3.85% |
| Q2 2024 | -4.00% |
| Q1 2024 | 30.56% |
| Q4 2023 | 17.53% |
| Q3 2023 | 21.29% |
| Q2 2023 | -83.40% |
| Q1 2023 | 23.83% |
| Q4 2022 | -117.65% |
| Q3 2022 | 36.93% |
| Q2 2022 | 27.48% |
| Q1 2022 | -56.21% |
| Q4 2021 | -106.72% |
| Q3 2021 | 1.12% |
| Q2 2021 | -21.50% |
| Q1 2021 | 39.53% |
| Q4 2020 | 29.17% |
| Q3 2020 | 22.58% |
| Q2 2020 | -1702.33% |
| Q1 2020 | -132.82% |
| Q4 2019 | -50.24% |
| Q3 2019 | -19.00% |
| Q2 2019 | 250.40% |
| Q1 2019 | -63.41% |
| Q4 2018 | 738.02% |
| Q3 2018 | 224.74% |
| Q2 2018 | 0.00% |